6 stories mentioning ASX:ACL
Every FINWIRES story that references ASX:ACL, newest first.
Australian Clinical Labs (ASX:ACL) said Greg Horan was appointed Group Chief Executive Officer and executive director, to succeed Melinda McGrath, according to a Thursday Australian bourse filing.Horan will join Australian Clinical Labs on June 1 as Group CEO-elect, and his term as Group CEO will take effect from Aug. 31.Horan was most recently CEO of Healthscope.
Australian Clinical Labs (ASX:ACL) said the Commonwealth Bank of Australia's (ASX:CBA) voting power in the company rose to 8.31% from 7.29% as of May 22, according to a Monday Australian bourse filing.The bank now holds 15.6 million ordinary shares of the firm.
Australian Clinical Labs (ASX:ACL) said an external IT service provider used by its SunDoctors subsidiary recently experienced a cyber incident where an unauthorized party gained access to a limited part of the unit's systems, according to a Thursday filing with the Australian bourse.SunDoctors has contained the issue, which impacted operations for a short period, and systems have all been restored. It is investigating the incident to determine if any sensitive personal information was compromised.Australian Clinical Labs said there was no impact on any of its own core laboratory systems or operations.The company's shares fell 1% in recent Thursday trade.
Australian Clinical Labs (ASX:ACL) said Macquarie Group (ASX:MQG) became a substantial holder on April 22 after acquiring 9.6 million securities of the firm, according to a Monday Australian bourse filing.Macquarie's voting power in the firm is now at 5.11%.Its shares fell 1% in recent trading on Monday.
Australian Clinical Labs (ASX:ACL) denied the claims made in the representative proceeding filed in the Victorian Supreme Court by a Michelle Raab-Ivanov and plans to "vigorously" defend it, according to a Tuesday filing with the Australian bourse.The proceeding was expressed to be on behalf of persons who were customers of the company and/or its Medlab Pathology subsidiary before July 15, 2022, and whose personal information was affected by a cyberattack on Medlab Pathology in February 2022, the filing said.The statement of claim purports to seek damages for affected individuals based on alleged breaches of the Australian Consumer Law, per the filing.
Australian Clinical Labs (ASX:ACL) said Pinnacle Investment Management Group and its subsidiaries have increased their stake in the company on April 13 to 6.67% or 12.6 million shares from 5.01% or 9.5 million shares, according to a Thursday Australian bourse filing.